Optical Coherence Tomography (OCT) and Contact Lens Growth Drives Ophthalmic Market Led by Carl Zeiss and Johnson and Johnson

January 11, 2011

Surge in Cataract Surgeries Fuel Intraocular Lens (IOL) Market to Almost
$1.4 Billion

VANCOUVER, Jan. 11 /PRNewswire/ – ccording to two new reports by iData Research
(www.idataresearch.net), the leading global authority in medical device and pharmaceutical
market research, growth in the use of optical coherence tomography
(OCT) for the detection of ocular conditions will drive the U.S.
diagnostic ophthalmic market to over $650 million by 2017. In addition,
the U.S. contact lens market is expected to reach over $4.6 billion due
to increased use of soft contact lenses and daily disposables by the
aging baby-boomer generation. Companies such as Johnson & Johnson, CIBA
Vision and CooperVision have emerged as the leading contact lens
manufacturers in 2010.

“OCT sales slowed in 2009 due to the recession, however their use is
growing in popularity among optometrists and ophthalmologists despite
rising prices,” says Dr. Douglas Fung, Analyst Manager at iData. “This
growth is due to the technologies’ superior resolution capabilities and
ability to image the vascular structure under the retina. Physicians
are expected to purchased second and third OCT units for their
practices, leading to double-digit growth rates through 2013.” 

iData’s reports state that the non-mydriatic/mydriatic combination
fundus camera segment was one of the fastest-growing in the diagnostic
ophthalmic market, increasing at a CAGR of over 15% in 2010.

“Fundus cameras help to diagnose conditions such as diabetic eye
disease, glaucoma and macular degeneration,” says Dr. Fung. “The market
is being driven by sales of combination devices from companies such as
Topcon and Canon, which provide a cost-effective all-in-one solution.”

iData’s interventional ophthalmic report states moreover that the
intraocular lens market is expected to reach almost $1.4 billion by
2017 due to advances in accommodative lenses that mimic the eye’s
natural ability to focus. Abbott’s Synchrony(R) accommodative IOL is
expected to gain FDA approval in 2011.

For more information on iData’s 2 report series on the “U.S. Markets for
Diagnostic & Interventional Ophthalmic Devices 2011″, register free on
iData’s website at:


About iData Research

iData Research (www.idataresearch.net/idata/discoveridata.php) is an international market research and consulting group focused on
providing market intelligence for medical device and pharmaceutical
companies. iData covers research in: ophthalmics, diabetes, surgical
equipment, and more.

SOURCE iData Research Inc.

Source: newswire

comments powered by Disqus